Topical calcitriol restores the impairment of epidermal permeability and antimicrobial barriers induced by corticosteroids.
Hong
S P
SP
Department of Dermatology, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea.
Oh
Y
Y
Jung
M
M
Lee
S
S
Jeon
H
H
Cho
M-Y
MY
Lee
S H
SH
Choi
E H
EH
D000287:Administration, Topical; D000818:Animals; D015153:Blotting, Western; D002117:Calcitriol / Q000494:pharmacology* / Q000627:therapeutic use; D002120:Calcium Channel Agonists / Q000494:pharmacology* / Q000627:therapeutic use; D002990:Clobetasol / Q000031:analogs & derivatives / Q000494:pharmacology; D004195:Disease Models, Animal; D004798:Enzymes / Q000378:metabolism; D004817:Epidermis / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D005260:Female; D005938:Glucocorticoids / Q000494:pharmacology; D007150:Immunohistochemistry; D051379:Mice; D008812:Mice, Hairless; D008854:Microscopy, Electron; D010078:Oxazines / Q000008:administration & dosage; D010539:Permeability / Q000187:drug effects; D016133:Polymerase Chain Reaction / Q000379:methods; D012869:Skin Absorption / Q000187:drug effects; D015854:Up-Regulation
D002120:Calcium Channel Agonists; D004798:Enzymes; D005938:Glucocorticoids; D010078:Oxazines; C021648:clobetasol 17-butyrate; D002990:Clobetasol; D002117:Calcitriol; C044808:nile red